Accuray(ARAY)
Search documents
Accuray Incorporated's Q2 2026 Earnings Overview
Financial Modeling Prep· 2026-02-05 08:00
Accuray Incorporated (NASDAQ:ARAY) reported an earnings miss with an EPS of -$0.11 against an estimated -$0.02, and revenue of $102.24 million versus the expected $121.19 million.The company's price-to-sales ratio stands at 0.19, and its enterprise value to sales ratio is 0.45, indicating a moderate valuation relative to sales.ARAY's debt-to-equity ratio is approximately 2.90, highlighting a higher reliance on debt financing, but it maintains a current ratio of 1.55, suggesting adequate liquidity.Accuray In ...
Accuray Q2 Earnings Call Highlights
Yahoo Finance· 2026-02-04 23:52
La Neve emphasized that cost actions are intended to support longer-term strategies, including efforts to strengthen commercial execution and create a more predictable, higher-margin growth model. He said Accuray has tightened weekly and monthly financial and operating reviews around orders, revenue, margins, service performance, and cash, with an emphasis on faster corrective actions and greater accountability.Management reiterated that the plan targets an approximately $25 million improvement in annualize ...
Accuray(ARAY) - 2026 Q2 - Earnings Call Transcript
2026-02-04 22:32
Accuray (NasdaqGS:ARAY) Q2 2026 Earnings call February 04, 2026 04:30 PM ET Company ParticipantsAli Pervaiz - CFOSteve La Neve - President and CEOSteve Monroe - VP of Financial Planning and AnalysisConference Call ParticipantsMarie Thibault - Managing Director and Medical Technology and Digital Health AnalystYoung Li - SVP and Equity Research AnalystOperatorGood afternoon and welcome to Accuray's conference call to review financial results for the second quarter of fiscal year 2026, which ended December 31s ...
Accuray(ARAY) - 2026 Q2 - Earnings Call Transcript
2026-02-04 22:32
Accuray (NasdaqGS:ARAY) Q2 2026 Earnings call February 04, 2026 04:30 PM ET Company ParticipantsAli Pervaiz - SVP and CFOSteve La Neve - CEOSteve Monroe - VP of Financial Planning and AnalysisConference Call ParticipantsMarie Thibault - Managing Director and Medical Technology and Digital Health AnalystYoung Li - SVP and Equity Research AnalystOperatorGood afternoon and welcome to Accuray's conference call to review financial results for the second quarter of fiscal year 2026, which ended December 31st of 2 ...
Accuray(ARAY) - 2026 Q2 - Earnings Call Transcript
2026-02-04 22:30
Accuray (NasdaqGS:ARAY) Q2 2026 Earnings call February 04, 2026 04:30 PM ET Speaker0Good afternoon and welcome to Accuray's conference call to review financial results for the second quarter of fiscal year 2026, which ended December 31st of 2025. All participants will be in a listen-only mode. Should you need assistance, please signal conference specialists by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press s ...
Accuray(ARAY) - 2026 Q2 - Earnings Call Presentation
2026-02-04 21:30
Q2'FY26 Earnings Call Supplemental Presentation February 4, 2026 Forward-looking Statements This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements i ...
Accuray(ARAY) - 2026 Q2 - Quarterly Results
2026-02-04 21:05
Exhibit 99.1 Accuray Reports Fiscal 2026 Second Quarter Financial Results MADISON, Wis, February 4, 2026 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025. Key Highlights "Over the past 90 days, I've met extensively with Accuray teams and customers across all major regions. Their insights have directly informed the decisive actions we've already taken — from reorganizing our commercial structure to refining our near‑term product and service ...
Accuray Reports Fiscal 2026 Second Quarter Financial Results
Prnewswire· 2026-02-04 21:05
MADISON, Wis., Feb. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025. Key Highlights "Over the past 90 days, I've met extensively with Accuray teams and customers across all major regions. Their insights have directly informed the decisive actions we've already taken — from reorganizing our commercial structure to refining our nearterm product and service investment priorities. We moved quickly and with discipline acr ...
Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
Prnewswire· 2026-01-21 21:05
Core Viewpoint - Accuray Incorporated will report its financial results for the second quarter of fiscal year 2026 on February 4, 2026, following the end of the quarter on December 31, 2025 [1]. Group 1: Financial Reporting - The financial results conference call will be hosted by company management at 1:30 p.m. PT/4:30 p.m. ET [1]. - Dial-in numbers for the conference call are provided for both the USA and international participants [2]. - A replay of the conference call will be available approximately one hour after its conclusion for one week [2]. Group 2: Webcast Information - A live webcast of the conference call will be accessible from the Investor Relations section of the company's website [3]. - The webcast replay will remain available until Accuray announces its results for the third quarter of fiscal 2026 [3]. Group 3: Company Overview - Accuray is focused on advancing radiation therapy to improve patient lives, offering innovative solutions for complex cases and enhancing treatment for commonly treatable cases [4]. - The company is dedicated to continuous innovation in radiation therapy for oncology and neuro-radiosurgery, collaborating with clinicians and administrators [4]. - Accuray is headquartered in Madison, Wisconsin, and has facilities worldwide [4].
Radiation Therapy-Focused Accuray Details Workforce Reduction, Outsourcing In Major Transformation Push
Benzinga· 2025-12-16 17:27
Core Viewpoint - Accuray Incorporated is undergoing a significant strategic transformation aimed at improving profitability through cost control, accountability, and enhanced execution [1] Group 1: Strategic Transformation - The initial phase of the transformation focuses on reshaping the operating model to enable faster decision-making and stronger sales execution [2] - The company is streamlining its commercial structure, centralizing core functions, and adjusting reporting lines to enhance accountability [3] - Accuray plans to optimize its workforce and physical footprint, aligning them with strategic priorities, and will outsource selected non-core activities [3] Group 2: Financial Impact - The transformation is expected to improve operating profitability by approximately $25 million on an annualized run-rate basis once fully implemented [2] - Compensation and benefits savings will account for the majority of the expected profit improvement, with around $12 million anticipated in fiscal 2026 [5] - The company expects to incur restructuring charges totaling about $11 million across its fiscal second, third, and fourth quarters due to the transformation [5] Group 3: Current Financial Performance - Accuray reported a first-quarter 2026 loss of 16 cents per share, missing the consensus loss of six cents, while sales reached $93.94 million, down 7% year over year [6] - The company reaffirmed its fiscal 2026 sales guidance of $471 million to $485 million, compared to the consensus of $475.15 million [6]